×
About 17,286 results

ALLMedicine™ Mood Disorders Center

Research & Reviews  8,207 results

Associations between diet quality and DSM-IV mood disorders during young- to mid-adulth...
https://doi.org/10.1007/s00127-021-02086-w 10.3945/ajcn.113.069880 10.1016/j.psychres.2017.04.020 10.1016/j.jad.2017.09.022 10.1038/s41380-018-0237-8 10.3945/ajcn.115.110213 10.1002/acr.20556 10.1080/09540260701564906 10.1001/archgenpsychiatry.2009.129 10.3945/ajcn.112.052761 10.1111/j.1467-842X.2000.tb00520.x 10.1093/jn/138.1.86 10.1016/j.nutres.2019.01.007 10.1192/S0007125000283001 10.1249/01.MSS.0000078924.61453.FB 10.1016/j.amepre.2008.09.036 10.1186/s12889-016-3931-y 10.1111/j.1541-0420.2011.01666.x 10.1016/j.jad.2020.07.048 10.2105/AJPH.79.3.340 10.1016/j.bbi.2018.01.002 10.1097/EDE.0b013e3181a819a1 10.1007/BF02310555 10.1017/S1368980016001531 10.1186/1471-244X-8-43 10.1186/s12916-015-0428-y 10.1017/s000711451500519x 10.1016/j.jad.2015.01.007 10.1016/j.jad.2020.05.046 10.1017/S0033291716000738 10.1017/S0033291719002800 10.3109/09540261.2010.492391 10.3945/ajcn.112.041582 10.1038/s41598-019-43085-x 10.1017/s1041610212001986 10.3945/ajcn.114.103846 10.1017/S1368980018001179 10.1177/2167702616638651 10.1186/1471-2458-11-119 10.1007/BF02874555 10.1007/s12529-018-9718-z 10.1176/appi.ajp.162.2.250 10.1093/ije/31.2.359 10.1038/sj.ejcn.1601929 10.3945/jn.110.133413 10.1016/0022-3956(94)90036-1 10.1093/ije/dyu038
Social Psychiatry and Psychiatric Epidemiology; Wilson JE, Blizzard L et. al.

May 7th, 2021 - Many studies have reported associations between diet and depression, but few have used formal diagnoses of mood disorder as the outcome measure. We examined if overall diet quality was associated cross-sectionally or longitudinally with DSM-IV moo...

Discovery of Non-racemic Amisulpride to Maximize Benefit/Risk of 5-HT7 and D2 Receptor ...
https://doi.org/10.1002/cpt.2282
Clinical Pharmacology and Therapeutics; Hopkins SC, Wilkinson S et. al.

May 7th, 2021 - In contrast to the dose-occupancy relationship in the treatment of schizophrenia, the minimal effective level of dopamine receptor 2 (D2R) blockade for antipsychotics in the treatment of bipolar depression is unknown. Lower doses aimed at relievin...

Interoceptive attention regulation in Ehlers-Danlos syndromes: associations between pai...
https://doi.org/10.1093/tbm/ibab049
Translational Behavioral Medicine; Niermeyer M, Ball D et. al.

May 5th, 2021 - High rates of comorbid chronic pain, anxiety, and mood disorders among individuals with the Ehlers-Danlos syndromes (EDS+) are becoming increasingly recognized, though this complex symptomology remains poorly understood and undertreated. The curre...

A honokiol-enriched Magnolia officinalis Rehder & E.H. Wilson. bark extract possesses a...
https://doi.org/10.1093/jpp/rgab067
The Journal of Pharmacy and Pharmacology; Borgonetti V, Governa P et. al.

May 5th, 2021 - The exposure of neurons to an excessive excitatory stimulation induces the alteration of the normal neuronal function. Mood disorders are among the first signs of alterations in the central nervous system function. Magnolia officinalis bark extrac...

Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells.
https://doi.org/10.1159/000515594
Neuroimmunomodulation Bauer ME, Teixeira AL

May 5th, 2021 - Mood disorders are associated with chronic low-grade systemic (sterile) inflammation, with increased plasma levels of pro-inflammatory mediators targeting all tissues including the brain. Importantly, pro-inflammatory cytokines (ex., tumor-necrosi...

see more →

Guidelines  41 results

ACOG Committee Opinion No. 757: Screening for Perinatal Depression.
https://doi.org/10.1097/AOG.0000000000002927
Obstetrics and Gynecology;

Jan 10th, 2019 - Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting on...

Screening for Perinatal Depression
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Obstetric-Practice/Screening-for-Perinatal-Depression

Oct 23rd, 2018 - Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting on.

Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recomm...
https://www.liebertpub.com/doi/10.1089/jwh.2018.27099.mensocrec
Maki, P.

Sep 4th, 2018 - There is a new appreciation of the perimenopause—defined as the early and late menopause transition stages as well as the early postmenopause—as a window of vulnerability for the development of both depressive symptoms and major depressive episode.

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the...
https://doi.org/10.1200/JCO.2018.79.2721
Journal of Clinical Oncology : Official Journal of the Am... Lyman GH, Greenlee H et. al.

Jun 11th, 2018 - Purpose The Society for Integrative Oncology (SIO) produced an evidence-based guideline on use of integrative therapies during and after breast cancer treatment that was determined to be relevant to the American Society of Clinical Oncology (ASCO)...

Clinical practice guidelines on the evidence-based use of integrative therapies during ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892208
CA: a Cancer Journal for Clinicians; Greenlee H, DuPont-Reyes MJ et. al.

Apr 24th, 2017 - Answer questions and earn CME/CNE Patients with breast cancer commonly use complementary and integrative therapies as supportive care during cancer treatment and to manage treatment-related side effects. However, evidence supporting the use of suc...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  8,523 results

Associations between diet quality and DSM-IV mood disorders during young- to mid-adulth...
https://doi.org/10.1007/s00127-021-02086-w 10.3945/ajcn.113.069880 10.1016/j.psychres.2017.04.020 10.1016/j.jad.2017.09.022 10.1038/s41380-018-0237-8 10.3945/ajcn.115.110213 10.1002/acr.20556 10.1080/09540260701564906 10.1001/archgenpsychiatry.2009.129 10.3945/ajcn.112.052761 10.1111/j.1467-842X.2000.tb00520.x 10.1093/jn/138.1.86 10.1016/j.nutres.2019.01.007 10.1192/S0007125000283001 10.1249/01.MSS.0000078924.61453.FB 10.1016/j.amepre.2008.09.036 10.1186/s12889-016-3931-y 10.1111/j.1541-0420.2011.01666.x 10.1016/j.jad.2020.07.048 10.2105/AJPH.79.3.340 10.1016/j.bbi.2018.01.002 10.1097/EDE.0b013e3181a819a1 10.1007/BF02310555 10.1017/S1368980016001531 10.1186/1471-244X-8-43 10.1186/s12916-015-0428-y 10.1017/s000711451500519x 10.1016/j.jad.2015.01.007 10.1016/j.jad.2020.05.046 10.1017/S0033291716000738 10.1017/S0033291719002800 10.3109/09540261.2010.492391 10.3945/ajcn.112.041582 10.1038/s41598-019-43085-x 10.1017/s1041610212001986 10.3945/ajcn.114.103846 10.1017/S1368980018001179 10.1177/2167702616638651 10.1186/1471-2458-11-119 10.1007/BF02874555 10.1007/s12529-018-9718-z 10.1176/appi.ajp.162.2.250 10.1093/ije/31.2.359 10.1038/sj.ejcn.1601929 10.3945/jn.110.133413 10.1016/0022-3956(94)90036-1 10.1093/ije/dyu038
Social Psychiatry and Psychiatric Epidemiology; Wilson JE, Blizzard L et. al.

May 7th, 2021 - Many studies have reported associations between diet and depression, but few have used formal diagnoses of mood disorder as the outcome measure. We examined if overall diet quality was associated cross-sectionally or longitudinally with DSM-IV moo...

Discovery of Non-racemic Amisulpride to Maximize Benefit/Risk of 5-HT7 and D2 Receptor ...
https://doi.org/10.1002/cpt.2282
Clinical Pharmacology and Therapeutics; Hopkins SC, Wilkinson S et. al.

May 7th, 2021 - In contrast to the dose-occupancy relationship in the treatment of schizophrenia, the minimal effective level of dopamine receptor 2 (D2R) blockade for antipsychotics in the treatment of bipolar depression is unknown. Lower doses aimed at relievin...

Interoceptive attention regulation in Ehlers-Danlos syndromes: associations between pai...
https://doi.org/10.1093/tbm/ibab049
Translational Behavioral Medicine; Niermeyer M, Ball D et. al.

May 5th, 2021 - High rates of comorbid chronic pain, anxiety, and mood disorders among individuals with the Ehlers-Danlos syndromes (EDS+) are becoming increasingly recognized, though this complex symptomology remains poorly understood and undertreated. The curre...

A honokiol-enriched Magnolia officinalis Rehder & E.H. Wilson. bark extract possesses a...
https://doi.org/10.1093/jpp/rgab067
The Journal of Pharmacy and Pharmacology; Borgonetti V, Governa P et. al.

May 5th, 2021 - The exposure of neurons to an excessive excitatory stimulation induces the alteration of the normal neuronal function. Mood disorders are among the first signs of alterations in the central nervous system function. Magnolia officinalis bark extrac...

Neuroinflammation in Mood Disorders: Role of Regulatory Immune Cells.
https://doi.org/10.1159/000515594
Neuroimmunomodulation Bauer ME, Teixeira AL

May 5th, 2021 - Mood disorders are associated with chronic low-grade systemic (sterile) inflammation, with increased plasma levels of pro-inflammatory mediators targeting all tissues including the brain. Importantly, pro-inflammatory cytokines (ex., tumor-necrosi...

see more →

News  477 results

New Data on Worldwide Mental Health Impact of COVID-19
https://www.medscape.com/viewarticle/947458

Mar 14th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A new survey that assessed the mental health impact of COVID-19 across the globe shows high rates of trauma and clinical mood disorders related to...

Cannabis Tied to Self-Harm, Death in Youth With Mood Disorders
https://www.medscape.com/viewarticle/945030

Jan 31st, 2021 - Adolescents and young adults with mood disorders and cannabis use disorder (CUD) are at significantly increased risk for self-harm, all-cause mortality, homicide, and death by unintentional overdose, new research suggests. Investigators found the ...

New Risks of Prescription Opioids Discovered
https://www.medscape.com/viewarticle/941170

Nov 16th, 2020 - Prescription opioid use increases the risk for major depressive disorder (MDD) and anxiety and stress-related disorders (ASRD), new genetic evidence shows. The findings also suggest MDD is a potential causal risk factor for increased prescription ...

Depression or Anxiety? Metabolic Blood Biomarkers May Tell the Tale
https://www.staging.medscape.com/viewarticle/938079

Sep 24th, 2020 - Metabolic alterations linked to inflammation and lipid metabolism can distinguish depression from anxiety and determine disease severity, new research suggests.  Results from a Dutch study included 1400 participants with anxiety, depression, or bo...

Depression or Anxiety? Metabolic Blood Biomarkers May Tell the Tale
https://www.medscape.com/viewarticle/938079

Sep 24th, 2020 - Metabolic alterations linked to inflammation and lipid metabolism can distinguish depression from anxiety and determine disease severity, new research suggests.  Results from a Dutch study included 1400 participants with anxiety, depression, or bo...

see more →

Patient Education  35 results see all →